Fertility

Event: Fertility Innovation Summit on April 20

In 2021 the team behind Women’s Health Innovation Summit is organizing a series of events leading up to its signature event in the fall. The second event in this series, the Fertility Innovation Summit will take place virtually on April 20, 2021. Women’s health today is under-served from innovation and clinical science standpoints with outdated practices and lack of much-needed attention from key players (incl.…

Rebrand: Fertility Focus’ OvuSense Sensor Is Changing Its Name to Ovucore

With the ultimate goal of increasing pregnancy rates in infertile couples by up to 50%, Fertility Focus, the company behind OvuSense, has pioneered a new approach to infertility diagnosis and treatment for many years. After recently expanding the range of fertility monitoring products that work with the OvuSense app, the company has now announced a rebrand. To help distinguish between the fertility…

Jubel Health Launches a Personal Fertility Companion App to Support Women on Their Reproductive Health and Wellness Journey

Earlier this week Jubel Health announced the launch of its app-based personal fertility guide. The platform was built together with leading reproductive doctors and other health experts as a one-stop-shop of resources to support women on their fertility journey.  The newly launched Jubel app has been in public beta for a while, and features 24/7 chat for personalized information and insights, fireside…

Brian E. Miller, Ph.D. joins TMRW as SVP of Sales to Help Bring the Company’s Technology to U.S. Fertility Clinics

TMRW Life Sciences, the creator of the world’s first and only automated technology platform for the management, identification, and storage of frozen eggs and embryos, announces today that Brian E. Miller, PhD, is joining TMRW’s senior leadership team as Senior Vice President of Sales. In his role, Brian will be responsible for bringing TMRW’s innovative technology to fertility clinics in the United States. Brian…

Clue Receives FDA Approval to Launch a Digital Contraceptive

Clue, the company behind the popular period tracking app, has announced that it has received FDA clearance to launch a digital contraceptive. The new functionality allows users to prevent pregnancy based only on the start date of a user’s period. This algorithmic prediction is based on Bayesian modelling. The app will display a high risk window across a number of days of…

Dr. Raquel Hammonds Joins Carrot Fertility as Director of Integrative and Preventative Medicine, a Newly Created Role at the Company

Dr. Raquel Hammonds is a Doctor of  Medicine in Naturopathic Medicine. She comes from The Center for Reproductive Health & Gynecology in Beverly Hills, California, where she worked with patients to uncover the root cause of subfertility/infertility in men and women undergoing IVF and IUI. In January Dr. Hammonds has now joined Carrot Fertility as Director of Integrative and Preventative Medicine, a…

Women’s Health Startup Maven Launches MavenRx, a Fertility Drug Delivery Service to Further Strengthen Its Fertility Program

Women’s and Family Health Startup Maven has announced the expansion of its award-winning fertility program with the launch of MavenRx. Through partnerships with two specialty pharmacies, Maven members can now receive industry-leading price discounts on their medications, complimentary same-day or next-day shipping nationwide, and on-demand, pharmacist-led unboxing and injection support. MavenRx adds a critical layer of support for all U.S.-based employees covered…

ExEm Foam, the Only FDA-Approved Contrast Agent for Ultrasound Tubal Patency Testing Is Now Available in the U.S.

ExEm Foam Inc announced today that ExEm Foam (air polymer-type A intrauterine foam), the only FDA-approved contrast agent for ultrasound tubal patency testing, is now available at select fertility clinics in the U.S.. The Foam procedure, a new ultrasound technique of hysterosalpingo foam sonography (HyFoSy), uses ExEm Foam to assess whether there may be a blockage in the fallopian tubes in women…